BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27612450)

  • 1. Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis.
    Ikić Matijašević M; Flegar D; Kovačić N; Katavić V; Kelava T; Šućur A; Ivčević S; Cvija H; Lazić Mosler E; Kalajzić I; Marušić A; Grčević D
    Clin Exp Immunol; 2016 Dec; 186(3):321-335. PubMed ID: 27612450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
    Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
    Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2
    Flegar D; Filipović M; Šućur A; Markotić A; Lukač N; Šisl D; Ikić Matijašević M; Jajić Z; Kelava T; Katavić V; Kovačić N; Grčević D
    Front Immunol; 2021; 12():767231. PubMed ID: 34925336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
    Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
    Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.
    Sućur A; Katavić V; Kelava T; Jajić Z; Kovačić N; Grčević D
    Int Orthop; 2014 Sep; 38(9):1893-903. PubMed ID: 24913769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
    Tanaka K; Hashizume M; Mihara M; Yoshida H; Suzuki M; Matsumoto Y
    Clin Exp Immunol; 2014 Feb; 175(2):172-80. PubMed ID: 24028747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome profiling of osteoclast subsets associated with arthritis: A pathogenic role of CCR2
    Filipović M; Flegar D; Aničić S; Šisl D; Kelava T; Kovačić N; Šućur A; Grčević D
    Front Immunol; 2022; 13():994035. PubMed ID: 36591261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.
    Mukai T; Gallant R; Ishida S; Kittaka M; Yoshitaka T; Fox DA; Morita Y; Nishida K; Rottapel R; Ueki Y
    Arthritis Rheumatol; 2015 Mar; 67(3):656-67. PubMed ID: 25470448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression.
    Yao Z; Li P; Zhang Q; Schwarz EM; Keng P; Arbini A; Boyce BF; Xing L
    J Biol Chem; 2006 Apr; 281(17):11846-55. PubMed ID: 16461346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hematopoietic stress in mice is followed by enhanced osteoclast maturation in the bone marrow microenvironment.
    Kuzmac S; Grcevic D; Sucur A; Ivcevic S; Katavic V
    Exp Hematol; 2014 Nov; 42(11):966-75. PubMed ID: 25051532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
    Yang X; Pande S; Scott C; Friesel R
    J Cell Biochem; 2019 Aug; 120(8):12450-12460. PubMed ID: 30805994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.
    Movila A; Ishii T; Albassam A; Wisitrasameewong W; Howait M; Yamaguchi T; Ruiz-Torruella M; Bahammam L; Nishimura K; Van Dyke T; Kawai T
    J Bone Miner Res; 2016 Sep; 31(9):1688-700. PubMed ID: 27082509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-dependent changes in trabecular bone turnover and osteogenic capacity of marrow cells during development of type II collagen-induced arthritis in mice.
    Nishida S; Tsurukami H; Sakai A; Sakata T; Ikeda S; Tanaka M; Ito M; Nakamura T
    Bone; 2002 Jun; 30(6):872-9. PubMed ID: 12052456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
    Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
    PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function.
    Charles JF; Hsu LY; Niemi EC; Weiss A; Aliprantis AO; Nakamura MC
    J Clin Invest; 2012 Dec; 122(12):4592-605. PubMed ID: 23114597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
    De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
    Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
    Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
    Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
    Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
    J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.